Reactive site peptide structural similarity between heparin cofactor II and antithrombin III - PubMed (original) (raw)
Comparative Study
. 1985 Feb 25;260(4):2218-25.
- PMID: 3838304
Free article
Comparative Study
Reactive site peptide structural similarity between heparin cofactor II and antithrombin III
M J Griffith et al. J Biol Chem. 1985.
Free article
Abstract
Heparin cofactor II (Mr = 65,600) was purified 1800-fold from human plasma to further characterize the structural and functional properties of the protein as they compare to antithrombin III (Mr = 56,600). Heparin cofactor II and antithrombin III are functionally similar in that both proteins have been shown to inhibit thrombin at accelerated rates in the presence of heparin. There was little evidence for structural homology between heparin cofactor II and antithrombin III when high performance liquid chromatography-tryptic peptide maps and NH2-terminal sequences were compared. A partially degraded form of heparin cofactor II was also obtained in which a significant portion (Mr = 8,000) of the NH2 terminus was missing. The rates of thrombin inhibition (+/- heparin) by native and partially degraded-heparin cofactor II were not significantly different, suggesting that the NH2-terminal region of the protein is not essential either for heparin binding or for thrombin inhibition. A significant degree of similarity was found in the COOH-terminal regions of the proteins when the primary structures of the reactive site peptides, i.e. the peptides which are COOH-terminal to the reactive site peptide bonds cleaved by thrombin, were compared. Of the 36 residues identified, 19 residues in the reactive site peptide sequence of heparin cofactor II could be aligned with residues in the reactive site peptide from antithrombin III. While the similarities in primary structure suggest that heparin cofactor II may be an additional member of the superfamily of proteins consisting of antithrombin III, alpha 1-antitrypsin, alpha 1-antichymotrypsin and ovalbumin, the differences in structure could account for differences in protease specificity and reactivity toward thrombin. In particular, a disulfide bond which links the COOH-terminal (reactive site) region of antithrombin III to the remainder of the molecule and is important for the heparin-induced conformational change in the protein and high affinity binding of heparin does not appear to exist in heparin cofactor II. This observation provides an initial indication that while the reported kinetic mechanisms of action of heparin in accelerating the heparin cofactor II/thrombin and antithrombin III/thrombin reactions are similar, the mechanisms and effects of heparin binding to the two inhibitors may be different.
Similar articles
- Antithrombin activity of fucoidan. The interaction of fucoidan with heparin cofactor II, antithrombin III, and thrombin.
Church FC, Meade JB, Treanor RE, Whinna HC. Church FC, et al. J Biol Chem. 1989 Feb 25;264(6):3618-23. J Biol Chem. 1989. PMID: 2914965 - Structure-function relationships in heparin cofactor II: chemical modification of arginine and tryptophan and demonstration of a two-domain structure.
Church FC, Villanueva GB, Griffith MJ. Church FC, et al. Arch Biochem Biophys. 1986 Apr;246(1):175-84. doi: 10.1016/0003-9861(86)90461-3. Arch Biochem Biophys. 1986. PMID: 3754413 - Antithrombin III: a backward glance o'er travel'd roads.
Seegers WH. Seegers WH. Adv Exp Med Biol. 1975;52:195-215. Adv Exp Med Biol. 1975. PMID: 47704 Review. - Mechanism of heparin action.
Jackson CM. Jackson CM. Baillieres Clin Haematol. 1990 Jul;3(3):483-504. doi: 10.1016/s0950-3536(05)80015-0. Baillieres Clin Haematol. 1990. PMID: 2176902 Review.
Cited by
- Potency and mass of factor VIII in FVIII products.
Butenas S, Parhami-Seren B, Gissel MT, Gomperts ED, Fass DN, Mann KG. Butenas S, et al. Haemophilia. 2009 Jan;15(1):63-72. doi: 10.1111/j.1365-2516.2008.01826.x. Epub 2008 Aug 6. Haemophilia. 2009. PMID: 18691375 Free PMC article. - Effect of BAX499 aptamer on tissue factor pathway inhibitor function and thrombin generation in models of hemophilia.
Gissel M, Orfeo T, Foley JH, Butenas S. Gissel M, et al. Thromb Res. 2012 Dec;130(6):948-55. doi: 10.1016/j.thromres.2012.08.299. Epub 2012 Aug 27. Thromb Res. 2012. PMID: 22951415 Free PMC article. - Matriptase-3 is a novel phylogenetically preserved membrane-anchored serine protease with broad serpin reactivity.
Szabo R, Netzel-Arnett S, Hobson JP, Antalis TM, Bugge TH. Szabo R, et al. Biochem J. 2005 Aug 15;390(Pt 1):231-42. doi: 10.1042/BJ20050299. Biochem J. 2005. PMID: 15853774 Free PMC article. - The tissue factor requirement in blood coagulation.
Orfeo T, Butenas S, Brummel-Ziedins KE, Mann KG. Orfeo T, et al. J Biol Chem. 2005 Dec 30;280(52):42887-96. doi: 10.1074/jbc.M505506200. Epub 2005 Oct 7. J Biol Chem. 2005. PMID: 16215234 Free PMC article. - Effect of locked-nucleic acid on a biologically active g-quadruplex. A structure-activity relationship of the thrombin aptamer.
Bonifacio L, Church FC, Jarstfer MB. Bonifacio L, et al. Int J Mol Sci. 2008 Mar;9(3):422-433. doi: 10.3390/ijms9030422. Epub 2008 Mar 24. Int J Mol Sci. 2008. PMID: 19325759 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources